BRFH
Barfresh Food Group, Inc.
BRFH's outlook is improving, though it still trails on the overall score.
CELH
Celsius Holdings, Inc.
CELH has the edge over BRFH overall, supported by stronger valuation and stronger fundamentals.
BRFH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
BRFH's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BRFH PE Valuation
BRFH has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BRFH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect BRFH's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BRFH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.22 | -$0.02 |
| Q1 2026 | -$0.16 | +$0.05 |
| Q4 2025 | -$0.17 | +$0.02 |
| Q3 2025 | -$0.19 | -$0.02 |
| Q2 2025 | -$0.20 | -$0.02 |
| Q1 2025 | -$0.21 | -$0.04 |
| Q4 2024 | -$0.19 | +$0.02 |
| Q3 2024 | -$0.17 | +$0.15 |
BRFH is still losing money, but far less than before: $0.22 per share over the past year, against $0.65 at its worst in late 2020.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BRFH on earnings quality, reporting a profit while its opponent remains loss making.
BRFH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.7M | +190% |
| Q1 2026 | $5.6M | +92% |
| Q4 2025 | $5.4M | +94% |
| Q3 2025 | $4.2M | +16% |
| Q2 2025 | $1.6M | +11% |
| Q1 2025 | $2.9M | +3.6% |
| Q4 2024 | $2.8M | +45% |
| Q3 2024 | $3.6M | +40% |
BRFH's revenue has grown year over year for eight quarters in a row: $5M last quarter, up 190% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -32% | +21 points |
| Q1 2026 | -7.7% | +18 points |
| Q4 2025 | -29% | +0.7 points |
| Q3 2025 | -6.2% | +7.6 points |
| Q2 2025 | -53% | N/A |
| Q1 2025 | -25% | N/A |
| Q4 2024 | -30% | N/A |
| Q3 2024 | -14% | N/A |
BRFH's operating margin was −32% last quarter, up 21 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BRFH on profitability, with a higher operating margin.
BRFH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$986K | +$149K |
| Q1 2026 | -$3M | -$2.5M |
| Q4 2025 | $426K | +$1.1M |
| Q3 2025 | -$546K | -$494K |
| Q1 2025 | -$534K | +$235K |
| Q4 2022 | -$29K | +$751.8K |
| Q3 2022 | -$696K | -$154.9K |
| Q2 2022 | -$790.3K | -$498.8K |
BRFH has burned cash in almost every quarter: −$4M over the past year, against −$2M the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over BRFH on cash generation, producing positive trailing cash flow while its opponent burns cash.
BRFH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +107K shares |
| 1 year | +3.1% | +488K shares |
| 3 years | +24% | +3.1M shares |
| 5 years | +34% | +4.1M shares |
| Available history | +61% | +6.1M shares |
BRFH has 16M diluted shares, up 3.1% from a year ago.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over BRFH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BRFH Net Leverage
BRFH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BRFH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.5 | Oversold |
| Stochastic | 2.8 | Oversold |
BRFH's weekly RSI is 20 (oversold) and its Stochastic is 3 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BRFH PE vs Consumer Defensive Sector
BRFH has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BRFH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.66 | 24% below |
| 20 week MA | $1.21 | 59% below |
| 50 week MA | $2.12 | 76% below |
| 100 week MA | $2.61 | 81% below |
| 200 week MA | $2.26 | 78% below |
BRFH is in a downtrend: it's below all five of its weekly moving averages, and 78% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over BRFH on trend strength, trading above more of its moving averages.
BRFH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.16 | $5.59 | +34% |
| 2021 | $5.59 | $5.98 | +7% |
| 2022 | $5.98 | $1.35 | -77% |
| 2023 | $1.35 | $1.59 | +18% |
| 2024 | $1.59 | $2.74 | +72% |
| 2025 | $2.74 | $2.68 | -2.2% |
| 2026 YTD | $2.68 | $0.50 | -81% |
BRFH is down 81% so far in 2026, after finishing higher in four of the previous six years.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over BRFH on returns for 2026, with the stronger performance.